Movement Alert｜DaVita HealthCare Partners Falls 5.94% in Pre-Market Trading, Q2 Beat Overshadowed by Unchanged Full-Year Guidance

Market Focus08-05

On August 5, DaVita HealthCare Partners fell 5.94% in pre-market trading, trading at $218.0/share, with turnover of $23,200.

The decline follows the company's Q2 earnings release, where adjusted EPS of $4.02 beat the consensus estimate of $3.88 by 3.61%, representing a 36.27% year-over-year increase from $2.95. Revenue of $3.554 billion also exceeded the $3.496 billion estimate. Despite the strong quarter, the company maintained its full-year adjusted EPS guidance at $14.10-$15.20, with a midpoint of $14.65 falling below the market consensus of $14.88. Given consecutive significant beats in Q1 and Q2, investors had widely anticipated a guidance raise, and the unchanged outlook is being interpreted as an implicit signal of decelerating earnings growth in the second half.

Adding to sentiment pressure, SEC filings revealed that Berkshire Hathaway recently sold 182,980 shares of DaVita at an average price of $199.55, though it still retains approximately 28.7 million shares.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1171935640?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-05 18:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171935640","market":"us","top_or_hot":-1,"title":"Movement Alert｜DaVita HealthCare Partners Falls 5.94% in Pre-Market Trading, Q2 Beat Overshadowed by Unchanged Full-Year Guidance","media":"Market Focus","content":"<p><p>On August 5, DaVita HealthCare Partners fell 5.94% in pre-market trading, trading at $218.0/share, with turnover of $23,200.</p><p>The decline follows the company's Q2 earnings release, where adjusted EPS of $4.02 beat the consensus estimate of $3.88 by 3.61%, representing a 36.27% year-over-year increase from $2.95. Revenue of $3.554 billion also exceeded the $3.496 billion estimate. Despite the strong quarter, the company maintained its full-year adjusted EPS guidance at $14.10-$15.20, with a midpoint of $14.65 falling below the market consensus of $14.88. Given consecutive significant beats in Q1 and Q2, investors had widely anticipated a guidance raise, and the unchanged outlook is being interpreted as an implicit signal of decelerating earnings growth in the second half.</p><p>Adding to sentiment pressure, SEC filings revealed that Berkshire Hathaway recently sold 182,980 shares of DaVita at an average price of $199.55, though it still retains approximately 28.7 million shares.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜DaVita HealthCare Partners Falls 5.94% in Pre-Market Trading, Q2 Beat Overshadowed by Unchanged Full-Year Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜DaVita HealthCare Partners Falls 5.94% in Pre-Market Trading, Q2 Beat Overshadowed by Unchanged Full-Year Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-05 18:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 5, DaVita HealthCare Partners fell 5.94% in pre-market trading, trading at $218.0/share, with turnover of $23,200.</p><p>The decline follows the company's Q2 earnings release, where adjusted EPS of $4.02 beat the consensus estimate of $3.88 by 3.61%, representing a 36.27% year-over-year increase from $2.95. Revenue of $3.554 billion also exceeded the $3.496 billion estimate. Despite the strong quarter, the company maintained its full-year adjusted EPS guidance at $14.10-$15.20, with a midpoint of $14.65 falling below the market consensus of $14.88. Given consecutive significant beats in Q1 and Q2, investors had widely anticipated a guidance raise, and the unchanged outlook is being interpreted as an implicit signal of decelerating earnings growth in the second half.</p><p>Adding to sentiment pressure, SEC filings revealed that Berkshire Hathaway recently sold 182,980 shares of DaVita at an average price of $199.55, though it still retains approximately 28.7 million shares.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DVA","symbol_name":"达维塔保健","start_time":0,"source_url":"","article_id":"1171935640","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171935640","pubTimestamp":1785924794,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 5, DaVita HealthCare Partners fell 5.94% in pre-market trading, trading at $218.0/share, with turnover of $23,200.The decline follows the company's Q2 earnings release, where adjusted EPS...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DVA":"达维塔保健"},"translate_title":"走势警报|DaVita HealthCare Partners 在盘前交易中下跌 5.94%，第二季度业绩因全年指引不变而蒙上阴影","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DVA":1},"content_text":"On August 5, DaVita HealthCare Partners fell 5.94% in pre-market trading, trading at $218.0/share, with turnover of $23,200.The decline follows the company's Q2 earnings release, where adjusted EPS of $4.02 beat the consensus estimate of $3.88 by 3.61%, representing a 36.27% year-over-year increase from $2.95. Revenue of $3.554 billion also exceeded the $3.496 billion estimate. Despite the strong quarter, the company maintained its full-year adjusted EPS guidance at $14.10-$15.20, with a midpoint of $14.65 falling below the market consensus of $14.88. Given consecutive significant beats in Q1 and Q2, investors had widely anticipated a guidance raise, and the unchanged outlook is being interpreted as an implicit signal of decelerating earnings growth in the second half.Adding to sentiment pressure, SEC filings revealed that Berkshire Hathaway recently sold 182,980 shares of DaVita at an average price of $199.55, though it still retains approximately 28.7 million shares.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1171935640","isCrawlerRequest":true}